Active	Status	Sponsor type	Region	Phase	Filter
7 Active 6 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shechter, Michael
NCT03840226: The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients	Recruiting	3	320	RoW	Placebo Oral Tablet, Placebo, Magnesium Oxide, Magnox 520 TM	Sheba Medical Center, Naveh Pharma (1996) Ltd.	Magnesium Deficiency, Heart Failure	01/26	03/26
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)	Recruiting	3	12500	Europe, Canada, Japan, US, RoW	Lepodisiran Sodium, LY3819469, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)	03/29	03/29
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Recruiting	3	10000	Europe, Canada, US, RoW	Retatrutide, LY3437943, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)	02/29	02/29
SUMMIT, NCT04847557: A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The Trial Feb 2024 - Dec 2024 : Data from SUMMIT trial in participants with heart failure with preserved ejection fraction and obesity	Completed	3	731	US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Heart Failure With Preserved Ejection Fraction (HFpEF)	07/24	07/24
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT01618123: Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit	Active, not recruiting	N/A	300	US, RoW		Sheba Medical Center, Mayo Clinic	Myocardial Infarction, Death, Cerebrovascular Accident, Congestive Heart Failure, Angina Pectoris	12/25	12/25
NCT02356393: Serum Magnesium Levels in Desalination Tap Water and Outcomes in Acute Myocardial Infarction Patients	Completed	N/A	150	RoW		Sheba Medical Center, Environment and Health Fund (EHF)	Myocardial Infarction, Death, Congestive Heart Failure, Acute-MI, Cardiovascular Disease	12/23	12/23